| 17-OHP | 17-hydroxyprogesterone |
| A4 | Androstenedione |
| ATA | American Thyroid Association |
| ASRM | American Society for Reproductive Medicine |
| BHP | Basic hormonal profile |
| CFT | Calculated free testosterone |
| DHEAS | Dehydroepiandrosterone sulfate |
| E2 | Estradiol |
| ENS | Encuesta Nacional de Salud (Chilean National Health Survey) |
| FSH | Follicle-stimulating hormone |
| GnRH | Gonadotropin-releasing hormone |
| HOMA | Homeostatic model assessment index |
| HPAG | Hypothalamic–pituitary–adrenal–gonadal axis |
| I0 × G60 | Product of fasting insulin × glucose at 60 min |
| IR | Insulin resistance |
| ISI | Insulin sensitivity index composite |
| LC-MS/MS | Liquid chromatography-tandem mass spectrometry |
| LH | Luteinizing hormone |
| OD | Ovulatory dysfunction |
| OGTT-I | Oral glucose tolerance test with insulin response |
| PAInT | Prolactin–Androgens–Insulin–Thyroid clinical framework |
| PCOS | Polycystic ovary syndrome |
| PMOS | Polyendocrine metabolic ovarian syndrome |
| POI | Premature ovarian insufficiency |
| PRL | Prolactin |
| RHRI | Reproductive Health Research Institute |
| SHBG | Sex hormone-binding globulin |
| TSH | Thyroid-stimulating hormone |
| TT | Total testosterone |
| URR | Upper reference range (TSH 2.5–5.0 μIU/mL; exploratory) |